Hypertension Diagnostics Inc

PINK:HDII USA Shell Companies
Market Cap
$0.98
Market Cap Rank
#51223 Global
#15897 in USA
Share Price
$0.00
Change (1 day)
+0.00%
52-Week Range
$0.00 - $0.00
All Time High
$0.19
About

Hypertension Diagnostics, Inc. designs, develops, manufactures, and markets proprietary noninvasive medical devices that detect subtle changes in the elasticity of arteries in the United States and internationally. It offers CVProfilor, which allows a physician to non-invasively assess the elasticity of small and large arteries, of which small artery elasticity is the earliest and sensitive marke… Read more

Hypertension Diagnostics Inc (HDII) - Total Liabilities

Latest total liabilities as of March 2023: $122.40K USD

Based on the latest financial reports, Hypertension Diagnostics Inc (HDII) has total liabilities worth $122.40K USD as of March 2023.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Hypertension Diagnostics Inc - Total Liabilities Trend (1997–2022)

This chart illustrates how Hypertension Diagnostics Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

Hypertension Diagnostics Inc Competitors by Total Liabilities

The table below lists competitors of Hypertension Diagnostics Inc ranked by their total liabilities.

Liability Composition Analysis (1997–2022)

This chart breaks down Hypertension Diagnostics Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio N/A Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity -0.16 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets N/A Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Hypertension Diagnostics Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Hypertension Diagnostics Inc (1997–2022)

The table below shows the annual total liabilities of Hypertension Diagnostics Inc from 1997 to 2022.

Year Total Liabilities Change
2022-06-30 $121.89K 0.00%
2021-12-31 $121.89K -93.89%
2021-06-30 $2.00 Million 0.00%
2020-12-31 $2.00 Million -5.84%
2020-06-30 $2.12 Million 0.00%
2019-12-31 $2.12 Million -65.35%
2017-12-31 $6.12 Million +8.05%
2016-12-31 $5.66 Million +254.98%
2012-12-31 $1.59 Million +83.98%
2011-06-30 $866.64K 0.00%
2010-12-31 $866.64K +132.50%
2009-06-30 $372.75K 0.00%
2008-12-31 $372.75K -37.27%
2007-12-31 $594.24K +17.55%
2006-12-31 $505.54K -14.36%
2005-12-31 $590.33K -7.26%
2004-12-31 $636.52K -38.35%
2003-12-31 $1.03 Million -42.79%
2002-12-31 $1.80 Million +275.95%
2001-12-31 $480.09K +14.06%
2000-12-31 $420.91K +110.46%
1999-12-31 $200.00K 0.00%
1997-12-31 $200.00K --